STATE STREET CORP - TALIS BIOMEDICAL CORP ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of TALIS BIOMEDICAL CORP
ValueSharesWeighting
Q2 2023$22,769
-6.2%
47,436
-4.2%
0.00%
Q1 2023$24,273
-44.9%
49,536
-50.0%
0.00%
Q4 2022$44,088
+29.7%
99,072
+100.0%
0.00%
Q3 2022$34,000
-17.1%
49,536
-1.9%
0.00%
Q2 2022$41,000
-88.5%
50,490
-79.9%
0.00%
Q1 2022$355,000
-66.8%
251,610
-5.5%
0.00%
Q4 2021$1,068,000
-28.4%
266,307
+11.6%
0.00%
Q3 2021$1,491,000
-34.3%
238,587
+15.9%
0.00%
Q2 2021$2,271,000
+20.2%
205,925
+40.0%
0.00%
Q1 2021$1,890,000147,0670.00%
Other shareholders
TALIS BIOMEDICAL CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Greenlight Capital 2,235,783$1,095,5340.06%
Baker Brothers Advisors 7,624,835$3,736,1690.02%
PRELUDE CAPITAL MANAGEMENT, LLC 223,934$109,7280.01%
ArrowMark Colorado Holdings LLC 478,862$234,6420.00%
WELLS FARGO & COMPANY/MN 167$820.00%
NORTHERN TRUST CORP 27,860$13,6520.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 144,416$70,7630.00%
STATE STREET CORP 49,536$24,2730.00%
MILLENNIUM MANAGEMENT LLC 163,663$800.00%
View complete list of TALIS BIOMEDICAL CORP shareholders